MEDICAMEN BIOTECH  
                     | 
                    
                
The Current P/E Ratio of MEDICAMEN BIOTECH  is 70.33.
                
| Share Price | ₹377.2 | Nov 03,2025 | 
| Market Cap | ₹512.9 Cr | |
| Earnings-TTM | ₹7.3 Cr | TTM-Consolidated Results | 
| Price/Earnings | 70.33x | Calculated as Market Cap/Earnings | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
                    P/E = 
                    Market Capitalization 
                    / Net Income 
                    
                    or, using per-share numbers:
                    
                    P/E = Stock Price / 
                    Earnings Per Share (EPS)
                
               
                                     Current Market Cap [ ₹512.9 Cr] as on Nov 03,2025                     
                    (/) Earnings [ ₹7.3 Cr] based on TTM-Consolidated Results
                                    
                
                (=) P/E Ratio [ 70.33x ]
            
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 70.33 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 61.52x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 53.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2025 at 93.43x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 51.31x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap | 
|---|---|---|---|
| MEDICAMEN BIOTECH | 7.29 | 70.33 | 512.9 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 39.34 | 409,626.0 | 
| DIVIS LABORATORIES LTD | 2,306.00 | 78.35 | 180,669.0 | 
| CIPLA LTD | 5,453.86 | 22.39 | 122,103.0 | 
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.34 | 122,793.0 | 
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.45 | 99,857.4 | 
| MANKIND PHARMA LTD | 1,905.51 | 52.03 | 99,138.4 | 
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.28 | 98,686.4 | 
| LUPIN LTD | 3,722.18 | 24.37 | 90,706.1 | 
| AUROBINDO PHARMA LTD | 3,417.93 | 19.68 | 67,259.7 | 
| ABBOTT INDIA LTD | 1,452.29 | 42.55 | 61,800.2 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio | 
|---|---|
| Min industry PE | 17.45x | 
| Max industry PE | 78.35x | 
| Median industry PE | 39.34x | 
| Average industry PE | 40.83x | 
You may also like the below Video Courses